CN113545480A - Health-care tabletting - Google Patents
Health-care tabletting Download PDFInfo
- Publication number
- CN113545480A CN113545480A CN202110844140.7A CN202110844140A CN113545480A CN 113545480 A CN113545480 A CN 113545480A CN 202110844140 A CN202110844140 A CN 202110844140A CN 113545480 A CN113545480 A CN 113545480A
- Authority
- CN
- China
- Prior art keywords
- burdock
- health
- asparagus
- gram
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000208843 Arctium Species 0.000 claims abstract description 26
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 26
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 26
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 20
- 241000018646 Pinus brutia Species 0.000 claims abstract description 20
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 20
- 241000234427 Asparagus Species 0.000 claims abstract description 19
- 235000005340 Asparagus officinalis Nutrition 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 239000002002 slurry Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 206010028980 Neoplasm Diseases 0.000 abstract description 8
- 201000011510 cancer Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 5
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 235000013619 trace mineral Nutrition 0.000 abstract description 4
- 239000011573 trace mineral Substances 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract description 2
- 206010022437 insomnia Diseases 0.000 abstract description 2
- 210000002307 prostate Anatomy 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SJVJMFXCINSXFF-UHFFFAOYSA-N 5-(5-prop-1-ynylthiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C#CC)=CC=C1C1=CC=C(C(O)=O)S1 SJVJMFXCINSXFF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- JIKZEPRTARLVKA-UHFFFAOYSA-N [Se].[I] Chemical compound [Se].[I] JIKZEPRTARLVKA-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a health care tablet, wherein the raw materials are measured according to the weight gram of the dry product of the extract, 0.3 to 0.9 gram of asparagus, 0.2 to 0.6 gram of burdock and 0.1 to 0.9 gram of pine pollen; has the advantages that: the asparagus, the burdock root and the pine pollen are combined together to furthest improve the effects of the asparagus, the burdock root and the pine pollen, play a role in complementation and promotion, and have various effects of preventing and inhibiting cancer, strengthening brain and intelligence, tonifying kidney, inhibiting insomnia, reducing high blood pressure, high blood fat, high blood sugar, high blood fat, high blood pressure, relaxing bowel, preventing cardiovascular diseases, enhancing blood vessel elasticity, resisting cell oxidation, improving the immunity of an organism, supplementing various trace elements, inhibiting prostate hyperplasia, protecting skin, beautifying and the like after being frequently taken.
Description
Technical Field
The invention relates to the field of health care products, in particular to a health care tablet.
Background
Along with the acceleration of the rhythm of life, the increase of working pressure, unhealthy diet and the deterioration of living environment, more and more people have reduced immunity and weak constitution, and sub-health conditions appear in many cases. Simple medication may also cause a number of side effects, which are not suitable for long-term use.
Disclosure of Invention
The invention aims to provide a health-care tablet for overcoming the defects that simple drug treatment in the prior art brings many side effects and is not suitable for long-term administration.
In order to achieve the purpose, the invention adopts the following technical scheme to realize the purpose:
a health tablet comprises 0.3-0.9 g of asparagus, 0.2-0.6 g of burdock and 0.1-0.9 g of pine pollen, wherein the raw materials are calculated according to the weight gram of dry extract.
Comprises the following raw materials in weight gram: 0.6 g of asparagus, 0.4 g of burdock and 0.5 g of pine pollen.
The preparation method of the health care tablet comprises the following steps:
1) pulverizing Germinatus Phragmitis and Burdock respectively to obtain Germinatus Phragmitis powder and Burdock powder;
2) adding water into pollen Pini, stirring and mixing to obtain pollen Pini slurry;
3) mixing and stirring the asparagus powder and the burdock powder uniformly to obtain mixed powder;
4) adding the pine pollen slurry into the mixed powder, stirring and mixing uniformly, tabletting, drying, and then coating and airing the granules to obtain the health-care tablet.
In the step 1), the fineness of the asparagus powder and the burdock powder are both 60-80 meshes.
In the step 2), the weight ratio of the pine pollen to the water is 15: 100.
in the step 4), the granulation is performed by using a rocking granulator with a 20-mesh screen.
In the step 4), the drying is carried out for 70-90 min at the temperature of 45-55 ℃.
In the step 4): the airing piece is as follows: airing the slices for 11-13 h under the conditions that the temperature is 18-26 ℃ and the humidity is 45% -65%.
The invention has the following beneficial effects: the asparagus, the burdock root and the pine pollen are combined together to furthest improve the effects of the asparagus, the burdock root and the pine pollen, play a role in complementation and promotion, and have various effects of preventing and inhibiting cancer, strengthening brain and intelligence, tonifying kidney, inhibiting insomnia, reducing high blood pressure, high blood fat, high blood sugar, high blood fat, high blood pressure, relaxing bowel, preventing cardiovascular diseases, enhancing blood vessel elasticity, resisting cell oxidation, improving the immunity of an organism, supplementing various trace elements, inhibiting prostate hyperplasia, protecting skin, beautifying and the like after being frequently taken.
Detailed Description
A health tablet comprises 0.3-0.9 g of asparagus, 0.2-0.6 g of burdock and 0.1-0.9 g of pine pollen, wherein the raw materials are calculated according to the weight gram of dry extract.
Comprises the following raw materials in weight gram: 0.6 g of asparagus, 0.4 g of burdock and 0.5 g of pine pollen.
The preparation method of the health care tablet comprises the following steps:
1) pulverizing Germinatus Phragmitis and Burdock respectively to obtain Germinatus Phragmitis powder and Burdock powder;
2) adding water into pollen Pini, stirring and mixing to obtain pollen Pini slurry;
3) mixing and stirring the asparagus powder and the burdock powder uniformly to obtain mixed powder;
4) adding the pine pollen slurry into the mixed powder, stirring and mixing uniformly, tabletting, drying, and then coating and airing the granules to obtain the health-care tablet.
In the step 1), the fineness of the asparagus powder and the burdock powder are both 60-80 meshes.
In the step 2), the weight ratio of the pine pollen to the water is 15: 100.
in the step 4), the granulation is performed by using a rocking granulator with a 20-mesh screen.
In the step 4), the drying is carried out for 70-90 min at the temperature of 45-55 ℃.
In the step 4): the airing piece is as follows: airing the slices for 11-13 h under the conditions that the temperature is 18-26 ℃ and the humidity is 45% -65%.
Asparagus has five big grams of cancer and a weapon to improve immunity:
1. abundant selenium iodine trace elements;
2. the abundant folic acid content can effectively prevent cancer cells from spreading;
3. histon nucleic acid and asparagine in free form;
4. the special soap compound has an inhibiting effect on cancer cells;
5. the extract can directly inhibit cancer cell growth and fission, and has no adverse side effect on normal cells.
6. Has health promoting, tonic, and immunity enhancing effects.
The burdock, also known as radix Panacis Quinquefolii, herba Verbenae, and burdock contains various vitamins and minerals required by human body such as inulin, cellulose, protein, calcium, phosphorus, ferrum, etc., wherein the carotene content is 150 times higher than that of radix Dauci Sativae, and the protein and calcium content are the first class of rhizome. The radix Arctii contains inulin and volatile oil, arctic acid, multiple polyphenols and aldehydes, and is rich in cellulose and amino acids.
Reducing blood sugar, blood lipid and blood pressure; invigorating kidney and strengthening yang; loosening bowel to relieve constipation; inhibiting cancer.
The nutritive value of the pine pollen is as follows:
pollen pini, like most of pollen, belongs to honey-derived pollen, is a germ cell of stamen in pine pollen, and contains an extremely rich nutrient substance.
The pollen Pini has effects of resisting oxidation, delaying aging, enhancing immunity, preventing infectious diseases such as virus and bacteria and cancer, reducing blood lipid, preventing cardiovascular diseases, strengthening brain, improving intelligence, improving sleep quality, improving digestive system function, lowering blood sugar, reducing blood lipid and cholesterol, enhancing blood vessel elasticity, inhibiting prostatic hyperplasia, caring skin, etc.
The pollen Pini contains a large amount of antioxidant substances, such as amino acids, nicotinic acid, pantothenic acid, vitamin A, vitamin E, vitamin C, vitamin B3, vitamin B6, vitamin B12, carotene, and trace elements such as iron and selenium.
Claims (8)
1. A health care tablet comprises asparagus, burdock and pine pollen, and is characterized in that: the raw materials are measured according to the weight gram of the dry product of the extract, and the asparagus is 0.3 to 0.9 gram, the burdock is 0.2 to 0.6 gram, and the pine pollen is 0.1 to 0.9 gram.
2. A health tablet according to claim 1, wherein: comprises the following raw materials in weight gram: 0.6 g of asparagus, 0.4 g of burdock and 0.5 g of pine pollen.
3. A health tablet according to any one of claims 1-2, wherein:
the preparation method of the health care tablet comprises the following steps:
1) pulverizing Germinatus Phragmitis and Burdock respectively to obtain Germinatus Phragmitis powder and Burdock powder;
2) adding water into pollen Pini, stirring and mixing to obtain pollen Pini slurry;
3) mixing and stirring the asparagus powder and the burdock powder uniformly to obtain mixed powder;
4) adding the pine pollen slurry into the mixed powder, stirring and mixing uniformly, tabletting, drying, and then coating and airing the granules to obtain the health-care tablet.
4. A health tablet according to claim 3, wherein: in the step 1), the fineness of the asparagus powder and the burdock powder are both 60-80 meshes.
5. A health tablet according to claim 3, wherein: in the step 2), the weight ratio of the pine pollen to the water is 15: 100.
6. a health tablet according to claim 3, wherein: in the step 4), the granulation is performed by using a rocking granulator with a 20-mesh screen.
7. A health tablet according to claim 3, wherein: in the step 4), the drying is carried out for 70-90 min at the temperature of 45-55 ℃.
8. A health tablet according to claim 3, wherein: in the step 4): the airing piece is as follows: airing the slices for 11-13 h under the conditions that the temperature is 18-26 ℃ and the humidity is 45% -65%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110844140.7A CN113545480A (en) | 2021-07-26 | 2021-07-26 | Health-care tabletting |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110844140.7A CN113545480A (en) | 2021-07-26 | 2021-07-26 | Health-care tabletting |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113545480A true CN113545480A (en) | 2021-10-26 |
Family
ID=78132756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110844140.7A Withdrawn CN113545480A (en) | 2021-07-26 | 2021-07-26 | Health-care tabletting |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113545480A (en) |
-
2021
- 2021-07-26 CN CN202110844140.7A patent/CN113545480A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101152007B (en) | Health-care products composition and method for preparing the same | |
| CN104997009B (en) | A kind of health food of anti-aging strengthen immunity and preparation method thereof | |
| CN103461631A (en) | Tea sugar food and making method thereof | |
| CN106266700A (en) | A kind of Fructus Hippophae prescription bag alveolitoid medicinal tea allotment and manufacture method | |
| CN111588833A (en) | Product for regulating hypertension | |
| CN102940155A (en) | Duckling feed for cherry valley duck and preparation method thereof | |
| CN105707387A (en) | Lycopene composite tablet candy and preparation method thereof | |
| CN110432482A (en) | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof | |
| CN102349608A (en) | Healthcare product combination for clearing and nourishing throat and preparation method thereof | |
| CN109007224A (en) | A kind of pressed candy and preparation method thereof containing Astaxanthin In Haematococcus Pluvialis conditioning female organism | |
| CN107173656A (en) | A kind of Chinese medicine fruits and vegetables probiotics fermented beverage and preparation method thereof | |
| CN1903278A (en) | Pure natural nutrient substance and its prepn. method | |
| CN105708970B (en) | A kind of health food with function of blood sugar reduction | |
| CN109077321A (en) | A kind of composition and preparation method thereof with strengthen immunity and antioxidation | |
| CN109007355A (en) | A kind of functional feed improving malnutritional anemia | |
| CN103142916B (en) | Medicament for preventing and treating senile dementia and preparation method thereof | |
| CN112674334A (en) | Whitening, beautifying and anti-saccharification blueberry powder compound solid preparation as well as preparation method and application thereof | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN113545480A (en) | Health-care tabletting | |
| CN115444134A (en) | Blueberry lutein ester chewable tablet and preparation method thereof | |
| CN101669640A (en) | Method for preparing health-care food by using ginkgo biloba extract (GBE) and bee pollen | |
| CN1142785C (en) | Antifatigue capsule | |
| CN114747765A (en) | Oral liquid for maintaining beauty and keeping young and preparation method thereof | |
| CN105661496A (en) | Korean red ginseng and radix angelicae dahuricae cell wall broken ultrafine powder preparation method | |
| CN1053378C (en) | Gingko seed and ginseng capsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20211026 |